Who owns ASPIRE BIOPHARMA HLDGS INC WT EXP 021430?
- Ticker: ASBPW
- CUSIP Number: 738920115
Tip: Access positions for across all investors
Analyze quarterly positions in Aspire Biopharma Hldgs Inc Wt Exp 021430 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aspire Biopharma Hldgs Inc Wt Exp 021430 stock
Who bought or sold ASPIRE BIOPHARMA HLDGS INC WT EXP 021430 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 1.1M | $17k | 0% | Dec 2025 |
|
| Saba Capital Management | 984k | $18k | 0% | Mar 2026 |
|
| Linden Advisors | 900k | $18k | 0% | Dec 2025 |
|
| Aristeia Capital | 682k | $12k | 0% | Mar 2026 |
|
| Highbridge Capital Management | 525k | $8.7k | -5% | Dec 2025 |
|
| Toronto-Dominion Bank | 516k | $8.8k | 0% | Mar 2026 |
|
| OZ Management | 500k | $9.1k | 0% | Mar 2026 |
|
| Verition Fund Management | 433k | $7.1k | 0% | Dec 2025 |
|
| Barclays | 350k | $5.8k | 0% | Dec 2025 |
|
| Clear Street Group | 331k | $5.5k | 100% | Mar 2026 |
|
| Millennium Management | 275k | $4.6k | 0% | Mar 2026 |
|
| Jpmorgan Chase & Co | 273k | $4.0k | 173% | Mar 2026 |
|
| Antara Capital | 208k | $3.4M | 0% | Dec 2025 |
|
| D. E. Shaw & Co | 200k | $3.3k | 0% | Mar 2026 |
|
| Wolverine Asset Management | 197k | $3.3k | 0% | Mar 2026 |
|
| Context Capital Management | 175k | $2.9k | 0% | Mar 2026 |
|
| Polar Securities | 139k | $2.5k | 0% | Mar 2026 |
|
| LMR Partners | 125k | $2.1k | 0% | Mar 2026 |
|
| Periscope Capital | 125k | $2.1k | 0% | Mar 2026 |
|
| Whitebox Advisors | 119k | $2.0k | 0% | Mar 2026 |
|
| VR Advisory Services | 100k | $1.7k | 0% | Mar 2026 |
|
| Limestone Investment Advisors | 75k | $1.2k | 0% | Dec 2025 |
|
| Blue Owl Capital Holdings | 50k | $1.0k | 0% | Dec 2025 |
|
| Picton Mahoney Asset Management | 50k | $830.000000 | 0% | Mar 2026 |
|
| Crossingbridge Advisors | 50k | $2.8k | 0% | Mar 2026 |
|
| OMERS Administration Corporation | 25k | $415.000000 | 0% | Mar 2026 |
|
| Mint Tower Capital Management B.V. | 25k | $26k | 0% | Mar 2026 |
|
| Athos Capital | 21k | $1.0k | 0% | Mar 2026 |
|
| Beacon Pointe Advisors | 20k | $330.000000 | 100% | Dec 2025 |
|
| Flow Traders US | 15k | $0 | 3% | Mar 2026 |
|
| Advisor Group Holdings | 50.00 | $0 | 0% | Dec 2025 |
|
| Investors Research Corp | 10.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Aspire Biopharma Hldgs Inc Wt Exp 021430?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 58k | $1.7k |